<DOC>
	<DOC>NCT00816803</DOC>
	<brief_summary>This study is designed to assess the safety of autologous bone marrow derived cell transplant in chronic spinal cord injury patients. The hypothesis is that the availability of bone marrow derived mesenchymal stem cells at the sites of injury promote neuronal regeneration.</brief_summary>
	<brief_title>Cell Transplant in Spinal Cord Injury Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Traumatic spinal cord injury No concomitant systemic disease No progress on physiotherapy for at least 6 months Duration of injury from 10 months to 3 years Nontraumatic spinal cord injury whether transverse myelitis or demyelination Concomitant systemic disease Progress can be observed on physiotherapy Acute injury or duration of injury less than 10 months</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>Spinal cord injury</keyword>
</DOC>